Disclaimer
The stock market is subject to significant volatility and inherent risks. Investing in stocks involves potential losses and is not guaranteed to generate profits. Prices of stocks can fluctuate unpredictably, We do not give any buy/sell tips. This article is for Educational purposes only.
Amwill Healthcare IPO is a book-built issue totaling ₹59.98 crores. This offering comprises a fresh issue of 44.04 lakh shares, amounting to ₹48.88 crores, and an offer for sale of 10.00 lakh shares, totalling ₹11.10 crores.
The Amwill Healthcare IPO will open for subscription on February 5, 2025, and close on February 7, 2025. The allotment for the IPO is expected to be finalized on Monday, February 10, 2025. The IPO will list on BSE SME, with the tentative listing date set for Wednesday, February 12, 2025.
The price band for the Amwill Healthcare IPO has been set at ₹105 to ₹111 per share. The minimum lot size for an application is 1,200 shares, and the minimum investment required by retail investors is ₹1,33,200. For HNI investors, the minimum lot size investment is 2 lots (2,400 shares), amounting to ₹2,66,400.
For detailed information and up-to-date updates on the Amwill Healthcare IPO GMP, as well as the IPO subscription status and allotment details, investors can turn to trusted platforms like IPO Watch, IPO Allotment BSE, or refer to the Amwill Healthcare Limited IPO Red Herring Prospectus (RHP). Staying updated on these vital aspects is crucial for making informed and strategic investment decisions in this IPO.
IPO Date | February 5, 2025 to February 7, 2025 |
Listing Date | 12 Feb 2025 |
Face Value | ₹10 per share |
Price Band | ₹105 to ₹111 per share |
Lot Size | 1,200 Shares |
Total Issue Size | 54,03,600 shares (aggregating up to ₹59.98 Cr) |
Fresh Issue | 44,03,600 shares (aggregating up to ₹ 48.88 Cr) |
Offer for Sale | 10,00,000 shares of ₹10 (aggregating up to ₹11.10 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 1,56,00,000 shares |
Share Holding Post Issue | 2,00,03,600 shares |
Market Maker Portion | Share Holding Pre-Issue |
IPO Open Date | Wednesday, February 5, 2025 |
IPO Close Date | Friday, February 7, 2025 |
Basis of Allotment | Monday, February 10, 2025 |
Initiation of Refunds | Tuesday, February 11, 2025 |
Credit of Shares to Demat | Tuesday, February 11, 2025 |
Listing Date | Wednesday, February 12, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on February 7, 2025 |
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 1200 | ₹1,33,200 |
Retail (Max) | 1 | 1200 | ₹1,33,200 |
HNI (Min) | 2 | 2,400 | ₹2,66,400 |
Investor Category | Shares Offered |
---|---|
QIB Shares Offered | Not more than 20.00% of the Net Issue |
Retail Shares Offered | Not less than 40.00% of the Net Issue |
NII (HNI) Shares Offered | Not less than 40.00% of the Net Issue |
Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
Assets | 20.14 | 12.39 | 6.59 | 8.29 |
Revenue | 36.05 | 30.28 | 27.62 | 18 |
Profit After Tax | 11 | 3.11 | 2.57 | -1 |
Net Worth | 15.63 | 4.6 | 1.49 | -1.09 |
Reserves and Surplus | 15.58 | 4.57 | 1.46 | -1.12 |
Maximizing Opportunities with Amwill Healthcare Limited IPO
The Amwill Healthcare Limited IPO presents a promising investment opportunity for those looking to invest in the growing healthcare sector. With a strong business model, an expanding product portfolio, and a solid track record, the company aims to strengthen its position in the industry. However, potential investors should carefully evaluate the company's financials, market conditions, and future growth prospects before making a decision. As with any investment, it’s essential to consider risk factors and consult with financial experts for informed decisions.